DOPACIS

This brand name is authorized in Spain, France, Malta

Active ingredients

The drug DOPACIS contains one active pharmaceutical ingredient (API):

1 Fluorodopa ¹⁸F UNII 2C598205QX - FLUORODOPA F-18

Fluorodopa F18 is a radioactive diagnostic agent used in PET imaging. In dopaminergic nerve terminals in the brain, fluorodopa (FDOPA) F18 is decarboxylated by amino acid decarboxylase to fluorodopamine (FDA) F18 and stored in presynaptic vesicles in the brain. The accumulation of F18 FDA in the striatum is visually detected in the PET scan. Read about Fluorodopa ¹⁸F

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DOPACIS Solution for injection	Medicines Authority (MT)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V09IX05	Fluorodopa (18F)	V Various → V09 Diagnostic radiopharmaceuticals → V09I Tumour detection → V09IX Other diagnostic radiopharmaceuticals for tumour detection
Discover more medicines within V09IX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 73797
Country: FR	Base de données publique des médicaments	Identifier(s): 62062343
Country: MT	Medicines Authority	Identifier(s): MA826/00101